JPWO2023144290A5 - - Google Patents
Info
- Publication number
- JPWO2023144290A5 JPWO2023144290A5 JP2024544412A JP2024544412A JPWO2023144290A5 JP WO2023144290 A5 JPWO2023144290 A5 JP WO2023144290A5 JP 2024544412 A JP2024544412 A JP 2024544412A JP 2024544412 A JP2024544412 A JP 2024544412A JP WO2023144290 A5 JPWO2023144290 A5 JP WO2023144290A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- day
- pharmaceutical composition
- dose
- cycles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263304424P | 2022-01-28 | 2022-01-28 | |
| US63/304,424 | 2022-01-28 | ||
| PCT/EP2023/051979 WO2023144290A1 (en) | 2022-01-28 | 2023-01-27 | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025503176A JP2025503176A (ja) | 2025-01-30 |
| JPWO2023144290A5 true JPWO2023144290A5 (https=) | 2026-02-10 |
| JP2025503176A5 JP2025503176A5 (https=) | 2026-02-10 |
Family
ID=85158800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544412A Pending JP2025503176A (ja) | 2022-01-28 | 2023-01-27 | びまん性大細胞型ｂ細胞リンパ腫を治療するための併用療法におけるｃｄ３及びｃｄ２０に対する二重特異性抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20230241211A1 (https=) |
| EP (1) | EP4469082A1 (https=) |
| JP (1) | JP2025503176A (https=) |
| KR (1) | KR20240135663A (https=) |
| CN (1) | CN118613281A (https=) |
| AU (1) | AU2023214116A1 (https=) |
| CA (1) | CA3243415A1 (https=) |
| IL (1) | IL314344A (https=) |
| MX (1) | MX2024008833A (https=) |
| TW (1) | TW202345895A (https=) |
| WO (1) | WO2023144290A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3176436A1 (en) | 2020-05-08 | 2021-11-11 | Tahamtan Ahmadi | Bispecific antibodies against cd3 and cd20 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| GB9203459D0 (en) | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| JP4213224B2 (ja) | 1997-05-02 | 2009-01-21 | ジェネンテック，インコーポレーテッド | ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法 |
| CN101928344B (zh) | 2002-10-17 | 2014-08-13 | 根马布股份公司 | 抗cd20的人单克隆抗体 |
| US7741568B2 (en) | 2005-01-13 | 2010-06-22 | The Wiremold Company | Downward facing receptacle assembly for cable raceway |
| EP3050963B1 (en) | 2005-03-31 | 2019-09-18 | Chugai Seiyaku Kabushiki Kaisha | Process for production of polypeptide by regulation of assembly |
| US10155816B2 (en) | 2005-11-28 | 2018-12-18 | Genmab A/S | Recombinant monovalent antibodies and methods for production thereof |
| ES2563027T3 (es) | 2008-01-07 | 2016-03-10 | Amgen Inc. | Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática |
| JP2012525149A (ja) | 2009-04-27 | 2012-10-22 | オンコメッド ファーマシューティカルズ インコーポレイテッド | ヘテロ多量体分子を作製するための方法 |
| TWI426920B (zh) | 2010-03-26 | 2014-02-21 | Hoffmann La Roche | 雙專一性、雙價抗－ｖｅｇｆ／抗－ａｎｇ－２抗體 |
| DK2560993T3 (da) | 2010-04-20 | 2024-10-14 | Genmab As | Heterodimeric antibody fc-containing proteins and methods for production thereof |
| US10344050B2 (en) | 2011-10-27 | 2019-07-09 | Genmab A/S | Production of heterodimeric proteins |
| MX373245B (es) | 2013-07-05 | 2020-05-11 | Genmab As | Anticuerpos cd3 humanizados o quiméricos. |
| WO2016007854A1 (en) * | 2014-07-11 | 2016-01-14 | Celgene Corporation | Combination therapy for cancer |
| CN107660214B (zh) | 2015-01-08 | 2022-02-08 | 根马布股份公司 | 针对cd3和cd20的双特异性抗体 |
| BR112020015052A2 (pt) | 2018-02-09 | 2020-12-08 | Genmab A/S | Composição farmacêutica, uso da composição farmacêutica, métodos para tratar câncer em um sujeito, para preparar uma composição farmacêutica e para preparar uma forma de dosagem unitária, forma de dosagem unitária, recipiente, e, kit-de-partes |
| KR20210104713A (ko) * | 2018-11-16 | 2021-08-25 | 주노 쎄러퓨티크스 인코퍼레이티드 | Ｂ 세포 악성 종양 치료를 위한 조작된 ｔ 세포 투약 방법 |
| EP4210742A1 (en) * | 2020-09-10 | 2023-07-19 | Genmab A/S | Bispecific antibody against cd3 and cd20 in combination therapy for treating follicular lymphoma |
-
2023
- 2023-01-27 CA CA3243415A patent/CA3243415A1/en active Pending
- 2023-01-27 US US18/160,386 patent/US20230241211A1/en active Pending
- 2023-01-27 MX MX2024008833A patent/MX2024008833A/es unknown
- 2023-01-27 US US18/833,261 patent/US20250115665A1/en active Pending
- 2023-01-27 KR KR1020247028130A patent/KR20240135663A/ko active Pending
- 2023-01-27 WO PCT/EP2023/051979 patent/WO2023144290A1/en not_active Ceased
- 2023-01-27 EP EP23702966.5A patent/EP4469082A1/en active Pending
- 2023-01-27 JP JP2024544412A patent/JP2025503176A/ja active Pending
- 2023-01-27 IL IL314344A patent/IL314344A/en unknown
- 2023-01-27 CN CN202380018858.8A patent/CN118613281A/zh active Pending
- 2023-01-27 AU AU2023214116A patent/AU2023214116A1/en active Pending
- 2023-01-30 TW TW112103163A patent/TW202345895A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025138634A (ja) | Ｂ細胞成熟抗原を標的にする多重特異性抗体のための投与計画及び組み合わせ治療 | |
| JP2021501162A5 (https=) | ||
| US20230048260A1 (en) | Therapeutic anti-cd40 ligand antibodies | |
| JP2021514973A5 (https=) | ||
| JP2020504723A5 (https=) | ||
| JP6324720B2 (ja) | 関節炎治療 | |
| CA2648223A1 (en) | Use of il-i antibodies for treating ophthalmic disorders | |
| JPWO2021183359A5 (https=) | ||
| JP2025032102A5 (https=) | ||
| IL297143A (en) | Anti-cd98 antibodies and their uses | |
| JP2021507677A (ja) | 抗ｔｒｋｂモノクローナル抗体および使用の方法 | |
| US12221485B2 (en) | TMEM219 antibodies and therapeutic uses thereof | |
| JPWO2022053654A5 (https=) | ||
| RS57708B1 (sr) | Antigen vezujući proteini specifični za p komponentu amiloida seruma | |
| JPWO2022053655A5 (https=) | ||
| JPWO2022053656A5 (https=) | ||
| JPWO2022053653A5 (https=) | ||
| JPWO2021224499A5 (https=) | ||
| JP2020505350A5 (https=) | ||
| JPWO2022053658A5 (https=) | ||
| JPWO2022053657A5 (https=) | ||
| JPWO2023144290A5 (https=) | ||
| IL319999A (en) | Bispecific antibodies against CD3 and CD20 - for the treatment of Richter syndrome | |
| JPWO2020257289A5 (https=) | ||
| IL314341A (en) | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma |